Table: Stella Pharma - 9-MTH parent results

Stella Pharma

10/02/2023 06:20

Feb 10 (Reuters)- 
             Stella Pharma Corporation 
             PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended        Year to  
                Dec 31, 2022        Dec 31, 2021      Mar 31, 2023  
                   LATEST             YEAR-AGO           LATEST     
                   RESULTS             RESULTS          FORECAST    
  Sales            175 mln             84 mln            220 mln    
                (+106.8 pct)         (-45.7 pct)      (+119.8 pct)  
  Operating     loss 503 mln        loss 517 mln      loss 850 mln  
  Recurring     loss 480 mln        loss 557 mln      loss 820 mln  
  Net           loss 483 mln        loss 560 mln      loss 823 mln  
  EPS          loss 16.85 yen      loss 20.08 yen    loss 28.55 yen 
  Ann Div                                NIL               NIL      
  -Q2 div            NIL                 NIL                        
  -Q4 div                                NIL               NIL      
  
  NOTE - Stella Pharma Corporation. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4888.T